Liminatus Pharma regains Nasdaq minimum bid price compliance after reverse stock splitPUBT·Sep 29, 2026 at 01:01 PMIRAALIMN-5.30%
Irenic Acquisition raises $252.5M in IPO including partial over-allotmentTradingView·May 7, 2026 at 04:43 PMIACQU0.00%IRAA
Irenic Acquisition prices $220M IPO, Nasdaq trading beginsbusinessinsider·Apr 27, 2026 at 10:02 PMIRAAIREX-22.53%
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and SynergiesTip Ranks·Mar 19, 2026 at 06:00 AMSBIO-4.02%CLPT-5.91%
IRIS Metals Issues New Shares to Cement U.S. Tungsten Farm-In DealTip Ranks·Mar 13, 2026 at 06:35 AMIRAAIRAAW0.00%
Iris Acquisition Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing February 24, 2026 | IRABU Stock NewsStockTitan·Feb 18, 2026 at 01:40 PMIRAAU0.00%IRAA
SPAC Iris Acquisition II prices $150 million US IPO, targeting small to mid-market businessesRenaissanceCapital·Feb 3, 2026 at 12:57 PMIRAAW0.00%IRAA
Iris Acquisition Corp II Announces Pricing of $150,000,000 Initial Public Offering | IRABU Stock NewsStockTitan·Feb 2, 2026 at 03:19 PMIRAA
